(NAR) VOL. 11 NOS.1-4 / JANUARY – MARCH 2000
The procedure and requirements for submission of application shall be in accordance with the provisions stated in the Guidelines for the Registration of Pharmaceutical Products issued under Bureau Circular No. 06, s. 1997 as amended by Bureau Circular No. 6, s. 1999.
To ensure a systematic process of filing applications, all concerned parties are enjoined to observe the specified schedule for pharmaceutical companies and the maximum number of applications that may be filed per schedule day.
Adopted: 23 July 1999
(SGD.) WILLIAM D. TORRES, PH.D.
Director